Trial Profile
Proof-of-Concept, CASAD for Treatment of Clostridium Difficile Infection
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 17 Jun 2014
Price :
$35
*
At a glance
- Drugs Calcium aluminium silicate (Primary)
- Indications Diarrhoea
- Focus Therapeutic Use
- Sponsors Salient Pharmaceuticals
- 17 Jun 2014 New trial record